Sahm Earnings
US$18.00 - That's What Analysts Think P3 Health Partners Inc. (NASDAQ:PIII) Is Worth After These Results
P3 Health Partners Inc. recently released solid second-quarter results, exceeding analyst revenue forecasts. Despite expectations of increased losses in 2026, analysts have raised their price target to US$18.00, suggesting confidence in the company's long-term intrinsic value. The company's revenue growth is also projected to outpace the wider industry, even with a forecasted slowdown from historical rates.